Tech Company Financing Transactions

CytoTronics Funding Round

CytoTronics secured a $13.5 million Seed funding round on 9/5/2024. Investors included Lyfe Capital, Anzu Partners and Draper Associates.

Transaction Overview

Company Name
Announced On
9/5/2024
Transaction Type
Venture Equity
Amount
$13,500,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to build off its early access program and accelerate market entry of their semiconductor-to-live-cell interface for cell biology applications, Pixel�.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Wareham St
Boston, MA 02118
United States
Phone
Undisclosed
Email Address
Not Recorded
Overview
CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform
Profile
CytoTronics LinkedIn Company Profile
Social Media
CytoTronics Company Twitter Account
Company News
CytoTronics News
Facebook
CytoTronics on Facebook
YouTube
CytoTronics on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Michele Giovenelli
  Michele Giovenelli LinkedIn Profile  Michele Giovenelli Twitter Account  Michele Giovenelli News  Michele Giovenelli on Facebook
Co-Founder
Duane Sword
  Duane Sword LinkedIn Profile  Duane Sword Twitter Account  Duane Sword News  Duane Sword on Facebook
Co-Founder
Vince Wu
  Vince Wu LinkedIn Profile  Vince Wu Twitter Account  Vince Wu News  Vince Wu on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/5/2024: Laravel venture capital transaction
Next: 9/5/2024: Acuvity venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary